Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 68-year-old man is evaluated in the hospital for acute, severe right knee pain and swelling that began 12 hours ago. His medical history is significant for a mechanical aortic valve replacement, chronic kidney disease stage 4 (baseline estimated glomerular filtration rate is 22 mL/min/1.73 m²), type 2 diabetes mellitus with neuropathy, and gout. His last gout flare was 3 years ago. Current medications include warfarin, linagliptin, insulin glargine, and allopurinol 100 mg daily. His temperature is 37.1°C (98.8°F), blood pressure is 138/82 mm Hg, and pulse is 78/min. Physical examination reveals a markedly swollen, erythematous, and warm right knee that is exquisitely tender to palpation. Range of motion is severely limited due to pain. Laboratory studies show an international normalized ratio (INR) of 2.8, hemoglobin of 12.1 g/dL, serum creatinine of 2.9 mg/dL, and a fasting serum glucose of 315 mg/dL with a hemoglobin A1c of 10.2%. Arthrocentesis of the right knee yields 30 mL of cloudy, yellow synovial fluid. Analysis of the fluid shows a leukocyte count of 55,000/mm³ (85% neutrophils). Polarized light microscopy demonstrates abundant negatively birefringent, needle-shaped crystals. Gram stain of the synovial fluid shows no organisms. Synovial fluid bacterial cultures are pending. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute knee condition?

  1. A
    Initiate oral indomethacin therapy
  2. B
    Administer a loading dose of oral colchicine
  3. C
    Initiate oral prednisone therapy
  4. D
    Initiate empiric intravenous vancomycin and ceftriaxone
  5. Administer intra-articular triamcinolone acetonideCevap

Cevap

Administer intra-articular triamcinolone acetonide
The correct intervention is administering intra-articular triamcinolone acetonide. The management of an acute gout flare typically involves NSAIDs, colchicine, or systemic corticosteroids. However, this patient's complex comorbidities present multiple contraindications: NSAIDs are contraindicated by his warfarin use and advanced chronic kidney disease; colchicine is contraindicated by his low eGFR (22 mL/min/1.73 m²); and systemic corticosteroids are contraindicated by his severely uncontrolled diabetes mellitus. Intra-articular glucocorticoid injection provides potent, localized anti-inflammatory effects with minimal systemic absorption, making it the safest and most effective option for this monoarticular flare.

Adım Adım Çözüm

1
Identify the primary diagnosis.
The patient has an acute gout flare, confirmed by monoarticular knee involvement and synovial fluid demonstrating negatively birefringent, needle-shaped crystals.
Accurate diagnosis is required before selecting pharmacologic therapy, differentiating gout from septic arthritis based on the negative Gram stain.
2
Evaluate systemic NSAIDs (e.g., indomethacin) for suitability.
Rule out NSAIDs.
NSAIDs are contraindicated due to the severe drug-drug interaction with warfarin (increased bleeding risk) and the presence of advanced chronic kidney disease.
3
Evaluate systemic colchicine for suitability.
Rule out colchicine.
Acute loading doses of colchicine are contraindicated in severe renal impairment (eGFR < 30 mL/min/1.73 m²) due to the risk of fatal systemic toxicity.
4
Evaluate systemic corticosteroids (e.g., oral prednisone) for suitability.
Rule out systemic corticosteroids.
Systemic corticosteroids are relatively contraindicated given the patient's severely uncontrolled type 2 diabetes mellitus (glucose 315 mg/dL), as they can precipitate a hyperosmolar hyperglycemic state.
5
Select the most appropriate remaining intervention.
Administer an intra-articular glucocorticoid injection.
Intra-articular injection (e.g., triamcinolone) provides targeted, localized anti-inflammatory therapy without the systemic adverse effects, making it the safest choice for this highly comorbid patient.

Anahtar Kavram

Management of acute gout flares requires careful synthesis of patient comorbidities to avoid severe drug-drug interactions and medication contraindications. When NSAIDs, colchicine, and systemic corticosteroids are all contraindicated, intra-articular corticosteroids are the intervention of choice for monoarticular flares.

Alternatif Yöntem

If multiple joints were involved (polyarticular flare) where intra-articular injections are impractical, and all systemic options are contraindicated, an IL-1 inhibitor such as anakinra could be considered off-label as an alternative therapy.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru